Home › Drug Codes › Q Codes › Q5159 · OSPOMYV AND XBRYK
Updated October 1st, 2026

OSPOMYV AND XBRYK Q Code: Q5159

Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
HCPCS Added Date October 1, 2025
Manufacturer Cordavis
Route of Administration Subcutaneous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About OSPOMYV AND XBRYK

Ospomyv AND Xbryk is a medication aligned to the HCPCS Q Code: Q5159 for billing, pricing, and reimbursement purposes in the United States. This Osteoporosis medication is administered via the subcutaneous route and manufactured by Cordavis.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to Q5159. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

OSPOMYV AND XBRYK Pricing & Reimbursement

Q5159 Private Payer Reimbursement
$16.27 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Denosumab Biosimilar Information:

OSPOMYV AND XBRYK Approval Date: February 13, 2025

Product Name HCPCS Code Active Ingredient BLA Type
Prolia J0897 Denosumab 351(a) Originator Product
Jubbonti and Wyost Q5136 Denosumab 351(k) Interchangeable
Ospomyv and Xbryk Q5159 Denosumab 351(k) Interchangeable
Stoboclo and Osenvelt Q5157 Denosumab 351(k) Interchangeable
Bomyntra and Conexxence Q5158 Denosumab 351(k) Interchangeable
Bildyos and Bilprevda Q5162 Denosumab 351(k) Interchangeable
Aukelso and Bosaya Q5161 Denosumab 351(k) Interchangeable
Enoby and Xtrenbo Q5167 Denosumab 351(k) Interchangeable
Osvyrti and Jubereq Q5166 Denosumab 351(k) Interchangeable
Oziltus Q5165 Denosumab 351(k) Interchangeable
Boncresa Q5171 Denosumab 351(k) Interchangeable
Ponlimsi Q5173 Denosumab 351(k) Interchangeable
One of 11 Prolia/Xgeva biosimilars FDA-approved since 2024 See each approval by month on the BuyandBill.com Pipeline calendar. Comes with Pro. Every denosumab approval, month by month.
Try a sample month → Open in Pipeline →

OSPOMYV AND XBRYK CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96372 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

OSPOMYV AND XBRYK Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Bone loss in men receiving androgen deprivation therapy for prostate cancer Bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer Glucocorticoid-induced osteoporosis Men with osteoporosis at high risk for fracture Postmenopausal women with osteoporosis at high risk for fracture
Drug Class
RANK Ligand Blocking Activity [MoA]RANK Ligand Inhibitor [EPC]

Try Pro free for 7 daysUpgrade to ProAdd Analytics and full history with ProComparative Report

Compare OSPOMYV AND XBRYK with PROLIA and its biosimilars

  • OSPOMYV AND XBRYK Q5159
  • PROLIA J0897
  • CONEXXENCE Q5158
  • Jubbonti Q5136
  • Bildyos Q5162
  • STOBOCLO AND OSENVELT Q5157

ASP, the Medicare payment limit, WAC and AWP for all 6 drugs on one timeline, with 10+ years of monthly history.

Card required · cancel anytime

Frequently Asked Questions

Is there an available Ospomyv And Xbryk billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for Ospomyv And Xbryk.
Are there any available Ospomyv And Xbryk patient assistance programs?
OSPOMYV AND XBRYK patient assistance information can be found through Cordavis. Visit Here →
Where can I find Ospomyv and Xbryk prescribing information?
Ospomyv And Xbryk prescribing information can be found through the link below. Visit Here →
Where can I find Ospomyv And Xbryk side effect information?
Ospomyv And Xbryk side effect information can be found at the link below. Visit Here →
Does billing Ospomyv And Xbryk require wastage modifiers?
CMS does not include OSPOMYV AND XBRYK (Q5159) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q5159. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Free account · Q5159

OSPOMYV AND XBRYK pricing you won’t find in public files

Create a free account to search every drug code, then try Pro free for 7 days to see ASP, WAC and AWP.

  • Free: payment limits for every code
  • 7-day Pro trial: ASP, WAC and AWP

Unlock with a 7-day Pro trial

ASP
Locked
WAC per billing unit
Locked
AWP per billing unit
Locked

10+

years of ASP, WAC and AWP price history

14,000+

NDC-to-HCPCS alignments built in-house, nearly twice the public crosswalks

Create your free account

  1. 1 Personal Info
  2. 2 About You
  3. 3 Credentials

Please use your company email. Personal addresses like Gmail or Yahoo aren’t accepted.

Personal Info

Already have an account? Log In